title: Is there a role yet for new direct oral anticoagulants in cancer patients?
authors.affiliation: Academic Section of Vascular Surgery, Division of Surgery, Department of Surgery & Cancer, Imperial College London, Charing Cross Hospital, London, UK.
authors.forename: Abigail L
authors.initials: AL
authors.lastname: Cohen
authors.affiliation: Academic Section of Vascular Surgery, Division of Surgery, Department of Surgery & Cancer, Imperial College London, Charing Cross Hospital, London, UK.
authors.forename: Chung S
authors.initials: CS
authors.lastname: Lim
authors.affiliation: Academic Section of Vascular Surgery, Division of Surgery, Department of Surgery & Cancer, Imperial College London, Charing Cross Hospital, London, UK a.h.davies@imperial.ac.uk.
authors.forename: Alun H
authors.initials: AH
authors.lastname: Davies
mesh_terms: D000284:Administration, Oral; D000925:Anticoagulants / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D009369:Neoplasms / Q000188:drug therapy*; D054556:Venous Thromboembolism / Q000209:etiology / Q000517:prevention & control*
chemical_list: D000925:Anticoagulants